Researcher Saul Priceman brings CAR T clinical trials to patients with solid tumor cancers

September 18, 2018 | Letisia Marquez

Saul Priceman, Ph.D., an assistant research professor with City of Hope’s T Cell Immunotherapy Laboratory, is focused on developing more CAR T clinical trials for patients battling solid tumor cancers like breast and prostate cancer.

Continue Reading

Researcher Saul Priceman brings CAR T clinical trials to patients with solid tumor cancers

September 18, 2018 | Letisia Marquez

Saul Priceman, Ph.D., an assistant research professor with City of Hope’s T Cell Immunotherapy Laboratory, is focused on developing more CAR T clinical trials for patients battling solid tumor cancers like breast and prostate cancer.

Research Grant Roundup

June 4, 2018 | City of Hope

Review the latest City of Hope grant awardees.

$2 million grant awarded to City of Hope to promote critical research on aging and cancer

June 1, 2018 | Letisia Marquez

The National Institute of Aging has awarded $2 million to City of Hope to establish a national research infrastructure that will facilitate and support significant innovative projects across the country addressing aging and cancer.

Looking Ahead: A Conversation with Steven T. Rosen, M.D., Provost and Chief Scientific Officer

May 30, 2018 | Michael Easterling

Steven T. Rosen, M.D., just marked his fourth year at City of Hope as provost and chief scientific officer. On the occasion of his first four years at City of Hope and the recent five-year renewal of a National Cancer Institute grant, we sat down with Rosen to reflect on his time at City of Hope.

Stephen Forman, M.D., Inducted into AAP

May 30, 2018 | Michael Easterling

Stephen J. Forman, M.D., the Francis & Kathleen McNamara Distinguished Chair in Hematology and Hematopoietic Cell Transplantation, has been inducted as a member of the Association of American Physicians.

Test Finds Promising New Drug to Treat Chronic Myelogenous Leukemia

May 15, 2018 | Katie Neith

City of Hope researchers may have discovered a more effective treatment for patients with chronic myelogenous leukemia (CML) according to a study published today in Nature Medicine.

Jianjun Chen, Ph.D., Takes Aim at Acute Myeloid Leukemia

May 15, 2018 | City of Hope

Jianjun Chen, Ph.D., a new faculty member at City of Hope, dedicates much of his research program to learning more about acute myeloid leukemia (AML), one of the most common and deadly forms of blood cancer.

City of Hope's Physician-in-Chief Michael Caligiuri Named AACR Fellow

May 14, 2018 | City of Hope

City of Hope President and Physician-in-Chief Michael A. Caligiuri, M.D., has been named a 2018 Fellow of the American Association for Cancer Research’s AACR Academy.